Literature DB >> 10772907

Paradoxical effects of mineralocorticoids on the ion gated sodium channel in embryologically diverse cells.

M Mirshahi1, N Golestaneh, F Valamanesh, M K Agarwal.   

Abstract

PCR analysis and Western blotting revealed the expression of the mineralocorticoid receptor (MCR) and the epithelial sodium channel (ENaC) genes at the level of RNA, DNA, and protein in several leukemic cell lines, fibroblasts from human cornea, and epithelial cells from ocular tissues. Following immunofluorescence, the MCR appeared to be primarily nuclear whereas the ENaC was almost exclusively membrane-bound. Paradoxically, the MCR-specific antagonist ZK 91587 actually stimulated the multiplication of human erythroblastic leukemia cells, contrary to the inhibitory effect of the antagonist RU 26752 on the multiplication of corneal fibroblasts; both effects were opposed by aldosterone. In quantitative PCR, both basal and aldosterone-induced levels of ENaC were diminished by ZK 91587 in the corneal fibroblast, in contrast to the stimulation observed in the retinal pigmentary epithelium. Thus, contrary to the existing notions, (a) antimineralocorticoids can act both as agonists and antagonists, and (b) the receptor-mediated action of mineralocorticoids on the sodium channel is not restricted to the epithelial cell. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10772907     DOI: 10.1006/bbrc.2000.2501

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  1 in total

1.  Family-based exome-wide assessment of maternal genetic effects on susceptibility to childhood B-cell acute lymphoblastic leukemia in hispanics.

Authors:  Natalie P Archer; Virginia Perez-Andreu; Michael E Scheurer; Karen R Rabin; Erin C Peckham-Gregory; Sharon E Plon; Ryan C Zabriskie; Pedro A De Alarcon; Karen S Fernandez; Cesar R Najera; Jun J Yang; Federico Antillon-Klussmann; Philip J Lupo
Journal:  Cancer       Date:  2016-08-16       Impact factor: 6.860

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.